Baidu
map

Nature Genetics:“渐冻人”研究新成果

2013-05-06 何嫱 生物通

来自北京大学第三医院、安徽医科大学第一附属医院等20多家机构的研究人员,通过全基因组关联分析鉴别了两个全新的肌萎缩侧索硬化症(amyotrophic lateral sclerosis,ALS)易感位点。相关研究论文于4月28日在线发表在国际顶级专业期刊《自然遗传学》(Nature Genetics)杂志上。 北京大学第三医院的鞠晓东(Xiaodong Ju)医生和安徽医科大学的汪凯(Kai W

来自北京大学第三医院、安徽医科大学第一附属医院等20多家机构的研究人员,通过全基因组关联分析鉴别了两个全新的肌萎缩侧索硬化症(amyotrophic lateral sclerosis,ALS)易感位点。相关研究论文于4月28日在线发表在国际顶级专业期刊《自然遗传学》(Nature Genetics)杂志上。

北京大学第三医院的鞠晓东(Xiaodong Ju)医生和安徽医科大学的汪凯(Kai Wang)教授为这篇论文的共同通讯作者。前者擅长运动创伤、膝关节疾患、关节镜手术。后者擅长脑血管疾病、神经系统变性病、癫痫以及周围神经病的诊断与治疗。对老年期神经系统疾病(如AD、PD)以及各种脑病引起的功能障碍(如记忆障碍、痴呆)以及情绪睡眠障碍有研究。

霍金所患的便是肌萎缩侧索硬化症

肌萎缩侧索硬化症是一种原因未明的运动神经元病。是神经内科在治疗上最为棘手的疾病之一,被列为世界五大绝症之首。据估计我国约有8万多人罹患本病,并且多数为中年人。

这种疾病的早期症状轻微,易与其他疾病混淆。患者可能只是感到有一些无力,肉跳、容易疲劳等一些症状,这些现象有时被误认为是年龄大了的正常现象。但随着时间的延长,肌肉力量不断减弱,进展为全身肌肉萎缩和吞咽困难,最后瘫痪并产生呼吸衰竭。随着病程的进展,患者如同一个健康人被”冻住”逐渐丧失各种行为能力。因此给予形象的称呼“渐冻人”。理论物理学大师斯蒂芬.霍金就是一位“渐冻人”。

世界各国的医学研究机构和临床研究人员正在集中力量探索其发病机制和治疗方法,我国神经病学的专家学者们也正为此做着积极不懈的努力。

在这篇文章中,研究人员采用一种称为“全基因组关联研究”(GWAS)的方法,开始寻找与这一疾病风险相关的易感基因。从来自506个散发性ALS患者和1,859个对照的遗传数据中,研究人员鉴别出了90个与ALS相关的“单核苷酸多态”(SNPs)。

研究人员随后在另一组独立的706个散发性ALS患者和1,777个正常对照样本中分析了这90个SNPs以及之前GWAS研究鉴定出的6个SNPs。由此研究人员发现了ALS的两个新风险位点,分别定位在t 1q32 (CAMK1G, rs6703183, Pcombined = 2.92 × 10-8, odds ratio (OR) = 1.31)和22p11 (CABIN1 and SUSD2, rs8141797, Pcombined = 2.35 × 10-9, OR = 1.52)。

这两个位点约占汉族众人疾病风险总体变异的12.48%。研究人员未在中国汉族人群中发现从前报道位点的关联证据,表明世系群体(ancestry group)之间ALS的疾病易感性存在有遗传异质性。

新研究鉴定出了2个与ALS相关的新的遗传区域,这些结果为推动对ALS发生发展机制的认识,同时也为ALS的预防和治疗提供了潜在的靶点。(生物谷Bioon.com)

doi:10.1038/ng.2627

PMC:
PMID:

Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis

Min Deng,Ling Wei,Xianbo Zuo,Yanghua Tian,Fei Xie,Panpan Hu,Chunyan Zhu,Fengqiong Yu,Yu Meng, Honghao Wang, Fangfang Zhang, Huijuan Ma, Rong Ye, Huaidong Cheng, Jing Du, Wenwen Dong, Shanshan Zhou, Changqing Wang, Yu Wang, Jingye Wang, Xianwen Chen, Zhongwu Sun, Nong Zhou, Yubao Jiang, Xiuxiu Liu, Xiaogang Li, Nan Zhang, Na Liu, Yingjun Guan, Yongsheng Han, Yongzhu Han, Xinyi Lv, Yu Fu, Hui Yu, Chunhua Xi, Dandan Xie, Qiyuan Zhao, Peng Xie, Xin Wang, Zhijun Zhang, Lu Shen, Yong Cui, Xianyong Yin, Hui Cheng, Bo Liang, Xiaodong Zheng,Tatia M C Lee, Gang Chen, Fusheng Zhou,Jan H Veldink, Wim Robberecht, John E Landers, Peter M Andersen, Ammar Al-Chalabi, Chris Shaw, Chunfeng Liu, Beisha Tang, Shangxi Xiao, Janice Robertson, Fengyu Zhang, Leonard H van den Berg, Liangdan Sun,Jianjun Liu, Sen Yang, Xiaodong Ju, Kai Wang & Xuejun Zhang et al.

To identify susceptibility genes for amyotrophic lateral sclerosis (ALS), we conducted a genome-wide association study (GWAS) in 506 individuals with sporadic ALS and 1,859 controls of Han Chinese ancestry. Ninety top SNPs suggested by the current GWAS and 6 SNPs identified by previous GWAS were analyzed in an independent cohort of 706 individuals with ALS and 1,777 controls of Han Chinese ancestry. We discovered two new susceptibility loci for ALS at 1q32 (CAMK1G, rs6703183, Pcombined = 2.92 × 10?8, odds ratio (OR) = 1.31) and 22p11 (CABIN1 and SUSD2, rs8141797, Pcombined = 2.35 × 10?9, OR = 1.52). These two loci explain 12.48% of the overall variance in disease risk in the Han Chinese population. We found no association evidence for the previously reported loci in the Han Chinese population, suggesting genetic heterogeneity of disease susceptibility for ALS between ancestry groups. Our study identifies two new susceptibility loci and suggests new pathogenic mechanisms of ALS.

(责任编辑:xiujuan.he)

分享到:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1922135, encodeId=4d14192213597, content=<a href='/topic/show?id=33915836275' target=_blank style='color:#2F92EE;'>#新成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58362, encryptionId=33915836275, topicName=新成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 04 23:53:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733629, encodeId=b27e1e336297c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 29 03:53:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879486, encodeId=f0e218e948691, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 13 08:53:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877932, encodeId=fa9f18e793234, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Fri Sep 13 11:53:00 CST 2013, time=2013-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685889, encodeId=b546168588994, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Thu Feb 06 00:53:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048505, encodeId=d421204850588, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri May 31 03:53:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1922135, encodeId=4d14192213597, content=<a href='/topic/show?id=33915836275' target=_blank style='color:#2F92EE;'>#新成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58362, encryptionId=33915836275, topicName=新成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 04 23:53:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733629, encodeId=b27e1e336297c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 29 03:53:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879486, encodeId=f0e218e948691, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 13 08:53:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877932, encodeId=fa9f18e793234, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Fri Sep 13 11:53:00 CST 2013, time=2013-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685889, encodeId=b546168588994, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Thu Feb 06 00:53:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048505, encodeId=d421204850588, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri May 31 03:53:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
    2013-08-29 canlab
  3. [GetPortalCommentsPageByObjectIdResponse(id=1922135, encodeId=4d14192213597, content=<a href='/topic/show?id=33915836275' target=_blank style='color:#2F92EE;'>#新成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58362, encryptionId=33915836275, topicName=新成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 04 23:53:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733629, encodeId=b27e1e336297c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 29 03:53:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879486, encodeId=f0e218e948691, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 13 08:53:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877932, encodeId=fa9f18e793234, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Fri Sep 13 11:53:00 CST 2013, time=2013-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685889, encodeId=b546168588994, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Thu Feb 06 00:53:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048505, encodeId=d421204850588, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri May 31 03:53:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
    2013-05-13 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=1922135, encodeId=4d14192213597, content=<a href='/topic/show?id=33915836275' target=_blank style='color:#2F92EE;'>#新成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58362, encryptionId=33915836275, topicName=新成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 04 23:53:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733629, encodeId=b27e1e336297c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 29 03:53:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879486, encodeId=f0e218e948691, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 13 08:53:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877932, encodeId=fa9f18e793234, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Fri Sep 13 11:53:00 CST 2013, time=2013-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685889, encodeId=b546168588994, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Thu Feb 06 00:53:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048505, encodeId=d421204850588, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri May 31 03:53:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
    2013-09-13 huperzia
  5. [GetPortalCommentsPageByObjectIdResponse(id=1922135, encodeId=4d14192213597, content=<a href='/topic/show?id=33915836275' target=_blank style='color:#2F92EE;'>#新成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58362, encryptionId=33915836275, topicName=新成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 04 23:53:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733629, encodeId=b27e1e336297c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 29 03:53:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879486, encodeId=f0e218e948691, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 13 08:53:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877932, encodeId=fa9f18e793234, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Fri Sep 13 11:53:00 CST 2013, time=2013-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685889, encodeId=b546168588994, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Thu Feb 06 00:53:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048505, encodeId=d421204850588, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri May 31 03:53:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1922135, encodeId=4d14192213597, content=<a href='/topic/show?id=33915836275' target=_blank style='color:#2F92EE;'>#新成果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58362, encryptionId=33915836275, topicName=新成果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Feb 04 23:53:00 CST 2014, time=2014-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1733629, encodeId=b27e1e336297c, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Aug 29 03:53:00 CST 2013, time=2013-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879486, encodeId=f0e218e948691, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon May 13 08:53:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877932, encodeId=fa9f18e793234, content=<a href='/topic/show?id=5d80e943ef' target=_blank style='color:#2F92EE;'>#Genetics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7943, encryptionId=5d80e943ef, topicName=Genetics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca89104, createdName=huperzia, createdTime=Fri Sep 13 11:53:00 CST 2013, time=2013-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685889, encodeId=b546168588994, content=<a href='/topic/show?id=66f3e93862' target=_blank style='color:#2F92EE;'>#Genet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7938, encryptionId=66f3e93862, topicName=Genet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3e128296421, createdName=江川靖瑶, createdTime=Thu Feb 06 00:53:00 CST 2014, time=2014-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048505, encodeId=d421204850588, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Fri May 31 03:53:00 CST 2013, time=2013-05-31, status=1, ipAttribution=)]
    2013-05-31 cy0324

相关资讯

eLife:海马齿状回利用不同的细胞群参与新旧记忆的编码

你是否曾在一个星期一的早上,绞尽脑汁得回忆你的车钥匙放在哪了。如果找到了,那你就该感谢一下你的海马了。海马是大脑中的一个重要结构,负责对不同环境的记忆进行编码和提取,比如你把你的车钥匙忘在了房间的某个角落。 如今,索尔克(Salk)生物研究所的科学家们帮我们解释了,大脑如何记忆生活中纷繁复杂的境况。他们发现了海马齿状回如何对相似的事件和环境进行分离,并把结果发表在了3月20日的eLife上。研究

Cell:探索神经细胞如何配备嗅觉受体

自然界中存在成千上万种气味分子,动物对这些气味分子有着惊人的识别能力。鼻中的嗅感觉神经元(Olfactory sensory neuron,OSNs)可以直接感知气味传送分子,然后向大脑发生信号。人类中有1000多种不同类型的OR基因,广泛分布于两条染色体上;小鼠、狗和其他的动物则有更多的OR基因。然而很久以来,生物学家们一直疑惑于,每个神经细胞如何只配备一种类型的嗅觉受体(OR)。 一个神经细

PLoS ONE:揭示神经肌肉障碍和嗅觉缺失的关联

2012年10月18日 讯 /生物谷BIOON/ --寒冷和呼吸道感染可以引发嗅觉和味觉能力的改变,但是嗅觉和味觉的改变或许也是神经变性疾病的初期征兆,如阿尔兹海默症和帕金森疾病等。近日,来自宾夕法尼亚大学的研究者揭示了嗅觉损伤和重症肌无力(MG)疾病之间的关联,重症肌无力是一种慢性的自体免疫神经肌肉疾病,其主要表现为脉动疲劳和肌肉无力等症状。相关研究成果刊登于国际杂志PLoS One上。 这项

Neuron:青少年大脑可塑性更强的机制被揭示

旋动某一分子开关,有助于生成成熟的神经元连接,为大脑构建起从青少年敏感性过渡到成人稳定性的桥梁。现在来自耶鲁大学医学院的研究人员逆转这一过程,在成年小鼠中构建出了记忆和痊愈能力提高的年轻大脑。相关研究发表在3月6日的《神经元》(Neuron)杂志上。 科学家们早就知道,年轻大脑和老年大脑存在很大的不同。青少年的大脑更具有可塑性,使得他们能比成年人能够更快地学习语言,加速从脑损伤中恢复。成人大

NRR:黄岑苷能促进慢性应激大鼠海马区的神经发生?

一项关于“Baicalin influences the dendritic morphology of newborn neurons in the hippocampus of chronically stressed rats”的研究,通过连续14 d皮下注射40 mg/kg糖皮质激素建立成年SD大鼠慢性应激模型,与此同时灌胃50 mg/kg的黄岑苷,观察其对慢性应激大鼠神经发生的影响。

NRR:黄岑苷能促进慢性应激大鼠海马区的神经再生?

一项关于“Baicalin influences the dendritic morphology of newborn neurons in the hippocampus of chronically stressed rats”的研究,通过连续14 d皮下注射40 mg/kg糖皮质激素建立成年SD大鼠慢性应激模型,与此同时灌胃50 mg/kg的黄岑苷,观察其对慢性应激大鼠神经发生的影响。

Baidu
map
Baidu
map
Baidu
map